A detailed history of Grimes & Company, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Grimes & Company, Inc. holds 21,744 shares of MRK stock, worth $2.52 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
21,744
Previous 21,551 0.9%
Holding current value
$2.52 Million
Previous $2.84 Million 5.35%
% of portfolio
0.08%
Previous 0.09%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

BUY
$123.8 - $132.96 $23,893 - $25,661
193 Added 0.9%
21,744 $2.69 Million
Q1 2024

Apr 17, 2024

SELL
$113.24 - $131.95 $31,820 - $37,077
-281 Reduced 1.29%
21,551 $2.84 Million
Q4 2023

Jan 24, 2024

SELL
$100.18 - $109.02 $11,821 - $12,864
-118 Reduced 0.54%
21,832 $2.38 Million
Q3 2023

Oct 19, 2023

BUY
$102.95 - $114.33 $411 - $457
4 Added 0.02%
21,950 $2.26 Million
Q2 2023

Jul 19, 2023

SELL
$108.61 - $118.38 $26,718 - $29,121
-246 Reduced 1.11%
21,946 $2.53 Million
Q1 2023

Apr 20, 2023

BUY
$102.94 - $114.86 $413,407 - $461,277
4,016 Added 22.1%
22,192 $2.36 Million
Q4 2022

Jan 25, 2023

BUY
$87.44 - $112.11 $39,260 - $50,337
449 Added 2.53%
18,176 $0
Q3 2022

Oct 28, 2022

SELL
$84.53 - $94.96 $9,044 - $10,160
-107 Reduced 0.6%
17,727 $1.53 Million
Q2 2022

Jul 22, 2022

BUY
$83.49 - $94.64 $17,866 - $20,252
214 Added 1.21%
17,834 $1.63 Million
Q1 2022

May 06, 2022

SELL
$73.51 - $82.4 $33,667 - $37,739
-458 Reduced 2.53%
17,620 $1.45 Million
Q4 2021

Feb 01, 2022

SELL
$72.28 - $90.54 $42,356 - $53,056
-586 Reduced 3.14%
18,078 $1.39 Million
Q3 2021

Nov 08, 2021

SELL
$71.68 - $78.83 $8,171 - $8,986
-114 Reduced 0.61%
18,664 $1.4 Million
Q2 2021

Aug 04, 2021

BUY
$70.31 - $77.77 $13,780 - $15,242
196 Added 1.05%
18,778 $1.46 Million
Q1 2021

May 12, 2021

BUY
$68.86 - $81.11 $107,352 - $126,450
1,559 Added 9.16%
18,582 $1.43 Million
Q4 2020

Feb 02, 2021

BUY
$71.77 - $79.65 $1.22 Million - $1.36 Million
17,023 New
17,023 $1.39 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $293B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Grimes & Company, Inc. Portfolio

Follow Grimes & Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grimes & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Grimes & Company, Inc. with notifications on news.